Intended for healthcare professionals


Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICE

BMJ 2023; 381 doi: (Published 19 May 2023) Cite this as: BMJ 2023;381:p1146
  1. Zosia Kmietowicz
  1. The BMJ

People who have had an ischaemic stroke or transient ischaemic attack should take a genetic test to see whether they can be treated with clopidogrel to reduce their risk of recurrence, the UK National Institute for Health and Care Excellence has said in draft guidance.1

NICE currently recommends that clopidogrel can be used as an option for treating people at risk of a secondary stroke, but this treatment is not …

View Full Text

Log in

Log in through your institution


* For online subscription